ROLE OF CONSERVATION THERAPY FOR INVASIVE LOBULAR CARCINOMA OF THE BREAST

Citation
M. Bouvet et al., ROLE OF CONSERVATION THERAPY FOR INVASIVE LOBULAR CARCINOMA OF THE BREAST, Annals of surgical oncology, 4(8), 1997, pp. 650-654
Citations number
24
Journal title
ISSN journal
10689265
Volume
4
Issue
8
Year of publication
1997
Pages
650 - 654
Database
ISI
SICI code
1068-9265(1997)4:8<650:ROCTFI>2.0.ZU;2-Q
Abstract
Background: Invasive lobular carcinoma (ILC) accounts for 5% to 10% of all invasive breast cancers, Although breast conservation therapy usi ng local excision and postoperative irradiation is a standard therapy for early invasive ductal breast cancer, the result of this strategy i n ILC is not well documented. We sought to determine the rate of locor egional recurrence after breast conservation therapy in patients with ILC. Methods: A retrospective review of 74 patients with ILC treated w ith breast conservation therapy at The University of Texas M. D. Ander son Cancer Center (n = 43) or The John Wayne Cancer Institute (n = 31) between 1977 and 1993 was performed. Results: The median age of patie nts was 60 years, and median follow-up was 56 months (range 1 to 207 m onths), Thirty-nine patients had American Joint Committee on Cancer st age I disease, 30 had stage II disease, and five had stage IIb disease . All patients underwent surgical resection and postoperative radiatio n therapy. Twelve patients received postoperative adjuvant chemotherap y, and 27 patients were treated with adjuvant hormonal therapy. The 5- year actuarial locoregional recurrence rate was 9.8%, and the median t ime to recurrence was 77 months (range 41 to 113 months). Patients wit h positive or close (less than or equal to 1 mm) surgical margins were at increased risk for local recurrence on univariate analysis (p = 0. 034). Of the nine patients with breast recurrence, six underwent salva ge therapy with total mastectomy and are disease free at the time of t his writing, two patients died of distant disease, and one is alive wi th local disease at the time of this report. The 5-year disease-specif ic survival rate was 93.7%. Conclusions: Breast conservation therapy f or ILC achieves locoregional control in the majority of patients, Howe ver, long-term follow-up of patients is important because many local r ecurrences following breast conservation therapy are late events.